Reginald Cannady, a postdoctoral research fellow at the Medical University of South Carolina, will discuss “Probing Novel Targets to Reduce Heavy Drinking in Models of Alcohol Use Disorder” at 4 p.m. Tuesday, Nov. 12, in Light Hall, Room 512, as part of the Discovery Science Emerging Scholars Lecture Series.
Individuals with alcohol use disorder (AUD) show an inability to regulate alcohol consumption and alcohol-seeking behavior. Although there are FDA‐approved medications for AUD, they have limited efficacy. Cannady’s work examines neuroadaptations caused by chronic alcohol experience and focuses on identifying neuronal targets to reduce heavy drinking using several rodent models of alcohol addiction. His presentation will discuss the validation of KV3 potassium channels as a potential therapeutic target to reduce alcohol consumption in preclinical models of alcohol dependence.
